跳转至内容
Merck
  • INF2-mediated actin filament reorganization confers intrinsic resilience to neuronal ischemic injury.

INF2-mediated actin filament reorganization confers intrinsic resilience to neuronal ischemic injury.

Nature communications (2022-10-14)
Barbara Calabrese, Steven L Jones, Yoko Shiraishi-Yamaguchi, Michael Lingelbach, Uri Manor, Tatyana M Svitkina, Henry N Higgs, Andy Y Shih, Shelley Halpain
摘要

During early ischemic brain injury, glutamate receptor hyperactivation mediates neuronal death via osmotic cell swelling. Here we show that ischemia and excess NMDA receptor activation cause actin to rapidly and extensively reorganize within the somatodendritic compartment. Normally, F-actin is concentrated within dendritic spines. However, <5 min after bath-applied NMDA, F-actin depolymerizes within spines and polymerizes into stable filaments within the dendrite shaft and soma. A similar actinification occurs after experimental ischemia in culture, and photothrombotic stroke in mouse. Following transient NMDA incubation, actinification spontaneously reverses. Na+, Cl-, water, and Ca2+ influx, and spine F-actin depolymerization are all necessary, but not individually sufficient, for actinification, but combined they induce activation of the F-actin polymerization factor inverted formin-2 (INF2). Silencing of INF2 renders neurons vulnerable to cell death and INF2 overexpression is protective. Ischemia-induced dendritic actin reorganization is therefore an intrinsic pro-survival response that protects neurons from death induced by cell edema.

材料
货号
品牌
产品描述

Sigma-Aldrich
环己酰亚胺 溶液, Ready-Made Solution, microbial, 100 mg/mL in DMSO, Suitable for cell culture
Sigma-Aldrich
抗NeuN抗体,克隆A60, clone A60, Chemicon®, from mouse
Sigma-Aldrich
(−)-II型肌球蛋白, solid, synthetic
Sigma-Aldrich
抗肌动蛋白抗体,克隆C4, ascites fluid, clone C4, Chemicon®
Sigma-Aldrich
抗-NeuN抗体, from chicken, purified by affinity chromatography
Sigma-Aldrich
红海海绵素A, from sea sponge, ≥85% (HPLC), waxy solid
Sigma-Aldrich
布美他尼, ≥98%
Sigma-Aldrich
CFTR抑制剂II,GlyH-101, CFTR Inhibitor II, GlyH-101, CAS 328541-79-3, is a cell-permeable potent, selective and reversible open-channel blocker of CFTR (Ki = 4.3 µM in CFTR-expressing FRT cells).
Sigma-Aldrich
C646, ≥98% (HPLC)
Sigma-Aldrich
Anti-Nckβ Antibody, Upstate®, from rabbit
Sigma-Aldrich
Anti-INF2 Antibody, from rabbit, purified by affinity chromatography